Outlook Therapeutics (41O.F) Q2 2026 Earnings

May 15Confirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-0.38
-0.27
-0.16
-0.05

Details

Expected EPS
-0.10422664173
Actual EPS
-0.1376304
Surprise EPS
-0.03
Surprise Percent
-32.05%

Description

⁨Outlook Therapeutics⁩ (⁦41O.F⁩) has reported earnings of ⁦-0.1376304⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts